Political party says the newly signed Trans-Pacific Partnership trade pact, which contains similar clauses to the Hong Kong deal, could prompt more costly challenges in The Hague
Slovakia will no longer have to compensate Achmea B.V., the shareholder of Union ZP health insurer, for €22 million in damage.
Regulating in the public interest at risk if Member States ratify Canada-EU trade deal
No-one knows what US will set as ’their requirements for that free trade agreement’, Prime Minister tells MPs.
Time and again, Canadians reaffirm their belief in the basic principle of equitable access to health care for all. But the spirit of this very Canadian principle remains in peril as NAFTA negotiations forge ahead.
Comment la simple menace d’un arbitrage international peut suffire à dissuader un pays de s’opposer aux intérêts d’une multinationale, c’est le "chilling effect".
Philippine civil society groups and social movements stand together to oppose RCEP
Tobacco giant Philip Morris has been ordered to pay the Australian government millions of dollars after unsuccessfully suing the nation over its world-first plain-packaging laws.
NAFTA blamed for tripling Canadians’ consumption of high-fructose sweeteners.
The current global trade and investment regime imposes high social and environmental costs on people and planet.
The Consumers’ Association of Penang calls on the Malaysian government not to make changes to the law relating to intellectual property rights to comply with the Trans-Pacific Partnership Agreement.
Although Canada won in a unanimous decision, the ruling does not, however, guarantee domestic discretion going forward, contrary to the suggestion of some.
A new briefing has outlined the likely elements of a UK-US trade deal and argues that it would contain more extreme forms of all the controversial elements of the deal that was being negotiated between the EU and the USA.
ISDS is an attempt to remove the risk of investment from companies, and place it squarely on the public’s shoulders, without any quid pro quo.
Novartis battle against Colombian Government highlights the threats to public health posed by the outrageous investor-state dispute settlement regime and bad “trade” deals.
Just the fact that the Canadian government had to go through this massive and expensive process for many years just for rejecting two bad patents should show why ISDS provisions are such a problem.
Canada has prevailed over pharmaceutical giant Eli Lilly in a long-running investor-state dispute the drug company filed under NAFTA’s investment chapter.
Taxpayers are still in the dark about how much of their money has been spent on fighting tobacco giant Philip Morris over plain packaging laws.
FIPA means province could be blocked from improving care standards for residents.
Interview with Dr Peter Ghys, interim director, strategic information and evaluation, UNAIDS